Alec Malloy

Content Writer

Alec Malloy is a content writer with over 7 years’ experience spanning a range of commercial sectors.

Although new to the world of finance and markets, he has plenty of experience working in other large-scale economic sectors. Amongst the industries Alec has covered are oil & gas, breakbulk, transport & logistics, food & drink trade, and construction. He has also previously written about music and video games for publications such as The Sun and GamesMaster magazine.


Contributions: 206

Opinions from Alec Malloy

Sun, 17 October 2021

Week Ahead

Week Ahead: Is hot UK inflation here to stay?

Quite a lot to look out for in terms of big data this week. First up, we have UK CPI data. Is inflation sticking around for longer than we thought?

Fri, 15 October 2021

ETF hopes power Bitcoin over $59,000

With the news Bitcoin exchange traded funds could be about to land in the US, BTC intensifies its upswing.

Thu, 14 October 2021


Earnings season: five stocks on Goldman’s radar

Earnings season is underway. Now’s the time to take a look at some stocks that could provide investors with more than the Wall Street consensus would tell you.

Sun, 25 July 2021

Week Ahead

Week Ahead: The Fed meets as inflation bites

The Fed meets as inflation starts to bite into the US economy. Will we see any major changes from Powell and co?

Tue, 20 July 2021


Oil retreats following OPEC+ decision as Covid fears mount

Following a month of strong gains, oil price action has retreated.

Mon, 19 July 2021

Cryptocurrency update: Bitcoin tipped for global finance shakeup

Bold predictions for Bitcoin this week, despite its recent woes. Could we be on the cusp of a worldwide financial revolution?

Sun, 18 July 2021

Week Ahead

Week Ahead: ECB to tilt after strategic shift?

The ECB clarifies its policy position following June’s strategic shift this week.

Thu, 15 July 2021


Vaccination shares: GSK vs Moderna

Moderna and GlaxoSmithKline represent two interesting paths pharmaceutical stocks have taken this year. We examine the GSK share price and Moderna shares to see which has come out on top – and what the future holds for both.

Tue, 13 July 2021

Cryptocurrency update: Bitcoin price drop prompts trading fall

The ongoing BTC lull and previous market crash may have caused a freefall in crypto trading volumes.

Tue, 13 July 2021

OPEC+ deadlock unresolved – what does this mean for the oil trade?

OPEC & allies are yet to reconvene its July meeting as supply pressures mount on the cartel. Will we see the deadlock broken soon?

Sun, 11 July 2021

Week Ahead

Week Ahead: Big banks kick of US earnings blitz

US earnings season is upon us. Big banks kick things off in what could be one of the best seasons for decades in terms of earnings growth for US large caps.

Thu, 8 July 2021


Is the ASOS share price on the rise?

Online fashion retailer ASOS is a familiar name to pretty much all UK fashionistas – but what about traders and investors? Does the ASOS share price make it one of the season’s hottest items?

Latest News

We're here to help

Phone Support

Our dedicated customer support team is here for you, round the clock, from Mon 00:00 to Friday 23:55 PM (GMT +2) which is Sun 22:00 PM – Friday 21:55 UK time.

Live Chat

Chat anytime directly to our customer support team via our live chat function. Our live chat is available 24/5 to answer your questions.

Knowledge Centre

Our Knowledge Centre is filled with essential advice and information about every aspect of trading and investing.

Trading Tools

From fundamental, to technical and sentiment tools, as well as our live XRay trading channel, we give you everything you need to trade smarter.


  • Client’s funds are kept in segregated bank accounts
  • FSCS Investor Compensation up to EUR20,000
  • 1,000,000 insurance cover** 
  • Negative Balance Protection


  • CFD
  • Share Dealing
  • Strategy Builder, operated by Safecap Investments Limited (“Safecap”) Regulated by CySEC under licence no. 092/08 and FSCA under licence no. 43906.


  • Clients’ funds kept in segregated bank accounts
  • Electronic Verification
  • Negative Balance Protection
  • $1,000,000 insurance cover** 


  • CFD
  • Strategy Builder, operated by Finalto (BVI) Ltd by the BVI Financial Services Commission (‘FSC’) under licence no. SIBA/L/14/1067.


  • Client’s funds are kept in segregated bank accounts
  • FSCS Investor Compensation up to GBP85,000
    *depending on criteria and eligibility
  • £1,000,000 insurance cover** 
  • Negative Balance Protection


  • CFD
  • Spread Bets
  • Strategy Builder operated by Finalto Trading Ltd. Regulated by the Financial Conduct Authority (“FCA”) under licence number 607305.


  • Clients’ funds kept in segregated bank accounts
  • Electronic Verification
  • Negative Balance Protection
  • $1,000,000 insurance cover**


  • CFD, operated by Finalto (Australia) Pty Ltd Holds Australian Financial Services Licence no. 424008 and is regulated in the provision of financial services by the Australian Securities and Investments Commission (“ASIC”).

Selecting one of these regulators will display the corresponding information across the entire website. If you would like to display information for a different regulator, please select it. For more information click here.

**Terms & conditions apply. Click here to read full policy.

An individual approach to investing.

Whether you’re investing for the long-term, medium-term or even short-term, Marketsi puts you in control. You can take a traditional approach or be creative with our innovative Investment Strategy Builder tool, our industry-leading platform and personalised, VIP service will help you make the most of the global markets without the need for intermediaries.

La gestión de acciones del grupo Markets se ofrece en exclusiva a través de Safecap Investments Limited, regulada por la Comisión de Bolsa y Valores de Chipre (CySEC) con número de licencia 092/08. Le estamos redirigiendo al sitio web de Safecap.


Are you lost?

We’ve noticed you’re on the site. As you are connecting from a location in the you should therefore consider re-entering , which is subject to the product intervention measures. Whilst you’re free to browse here on your own exclusive initiative, viewing the site for your country will display the corresponding regulatory information and relevant protections of the company you choose. Would you like to be redirected to ?